Effect of amlodipine upon the protective activity of antiepileptic drugs against maximal electroshock-induced seizures in mice

Pharmacological Research

Volumn 40, Issue 4, 1999, Pages 319-325

  Kaminski, R ^a   Jasinski, M ^a   Jagiello Wojtowicz, E ^a   Kleinrok, Z ^a   Czuczwar, S J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anticonvulsants; Calcium antagonists; Seizures

Indexed keywords

AMLODIPINE; ANTICONVULSIVE AGENT; CALCIUM ANTAGONIST; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROCONVULSIVE THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

EID: 0032824984     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0518     Document Type: Article

References (39)

1. +potential. Ann Neurol. 10:1981;11-17.
2. Pumain R, Kurcewicz I, Louvel J. Fast extracellular calcium transients: involvement in epileptic processes. Science. 222:1983;177-179.
3. Vreugdenhill M, Wadman W J. Enhancement of calcium currents in rat hippocampal CA1 neurons induced by kindling epileptogenesis. Neuroscience. 49:1992;373-381.
4. Speckmann E J, Stroub H, Köhling R. Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism. Neuropsychobiology. 27:1993;122-126.
5. Dolin S J, Hunter A B, Halsey M J, Little H J. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine. Eur J Pharmacol. 152:1988;19-27.
6. Czuczwar S J, Malek U, Kleinrok Z. Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology. 29:1990;943-948.
7. Brain Res Bull. 25:1990;211-214.
8. Jagiello-Wójtowicz E, Czuczwar S J, Chodkowska E, Szponar J, Kleinrok Z. Influence of calcium channel blockers on pentylenetetrazol and electroshock-induced convulsions in mice. Pol J Pharmacol Pharm. 43:1991;95-101.
9. Rodger C, Pleuvry B J. Protective effect of flunarizine and nifedipine alone or in combination with anticonvulsant drugs against PTZ-induced seizures in mice. Neuropharmacology. 32:1993;257-263.
10. Gasior M, Kamiński R, Brudniak T, Kleinrok Z, Czuczwar S J. Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. J Neural Transm. 103:1996;819-831.
11. Czuczwar S J, Chodkowska A, Kleinrok Z, Malek U, Jagiello-Wójtowicz E. Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. Eur J Pharmacol. 176:1990;75-83.
12. Czuczwar S J, Gasior M, Janusz W, Kleinrok Z. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology. 31:1992;1179-1183.
13. De Sarro G B, Meldrum B S, Nistico G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol. 93:1988;247-256.
14. Palmer G C, Stagnitto M L, Ray R K, Knowles M A, Harvey R, Garske G E. Anticonvulsant properties of calcium channel blockers in mice: N -methyl- d -, l -aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Epilepsia. 34:1993;372-380.
15. Cramer C L, Stagnitto M L, Knowles M A, Palmer G C. Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life Sci. 54:1994;271-275.
16. Shelton R C, Grebb J A, Freed W J. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k-8644. Brain Res. 402:1987;399-402.
17. Gasior M, Kleinrok Z, Czuczwar S J. Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional antiepileptics against electroconvulsions in mice. Neuropharmacology. 34:1995;433-438.
18. 2+channel agonist, BAY k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptors antagonists. Eur J Pharmacol. 264:1994;103-106.
19. Epilepsia. 26:1985;424-428.
20. Meyer F B, Cascino G D, Whisnant J P, Sharbrough F W, Ivnik R J, Gorman D A, Windschitl W L, So E L, O'Fallon W M. Nimodipine as an add-on therapy for intractable epilepsy. Mayo Clin Proc. 70:1995;623-627.
21. Abernethy D R. The pharmacokinetic profile of amlodipine. Am Heart J. 118:1989;1100-1103.
22. Meredith P A, Elliott H L. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 22:1992;22-31.
23. Burges R, Moisey D. Unique pharmacologic properties of amlodipine. Am J Cardiol. 73:1994.
24. Litchfield J T, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 96:1949;99-113.
25. Boissier J R, Tardy J, Diverres J C. Une nouvelle méthode simple pour explorer l'action 'tranquilisante': le test de la chiminée. Med Exp (Basel). 3:1960;81-84.
26. Venault P, Chapoutier G, De Carvalho L P, Simiand J, Morre M, Dodd R H, Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature. 321:1986;864-866.
27. Patsalos P N, Duncan J S. Antiepileptic drugs. Drug Saf. 9:1993;156-184.
28. Drobitch R K, McLellan R A, Renton K W. Amlodipine inhibits rat microsomal cytochrome P450-mediated drug biotransformation. J Pharm Sci. 86:1997;1501-1503.
29. Borowicz K K, Gasior M, Kleinrok Z, Czuczwar S J. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. Eur J Pharmacol. 323:1997;45-51.
30. Czuczwar S J, Turski W A, Kleinrok Z. Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs. CNS Drug Rev. 2:1996;452-467.
31. Flaim S F, Kanda K. Comparative pharmacology of calcium blockers based on studies of cardiac output distribution. Flaim S F, Zelis R,. Calcium blockers: mechanisms of action and clinical applications. 1982;179-192 Urban and Schwarzenberg, Baltimore:
32. Župan G, Vitezić D, Mršić J, Matešić D, Simonić A. Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat. Eur J Pharmacol. 310:1996;103-106.
33. Quartermain D, Hawxhurst A, Ermita B, Puente J. Effect of calcium channel blocker amlodipine on memory in mice. Behav Neural Biol. 60:1993;211-219.
34. Clements M P, Rose S P, Tiunova A. omega-Conotoxin GIVA disrupts memory formation in the day-old chick. Neurobiol Learn Mem. 64:1995;276-284.
35. Stefani A, Spadoni F, Bernardi G. Voltage-activated calcium channels: targets of antiepileptic drug therapy. Epilepsia. 38:1997;959-965.
36. Kelly K M, Gross R A, Macdonald R L. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett. 116:1990;233-238.
37. Werz M A, Macdonald R L. Barbiturates decrease voltage-dependent calcium conductance of mouse neurons in dissociated cell culture. Mol Pharmacol. 28:1985;269-277.
38. Gross R A, Macdonald R L. Differential actions of pentobarbitone on calcium current components of mouse sensory neurons in culture. J Physiol (London). 405:1988;187-203.
39. Hough C J, Irwin P, Gao X M, Rogawski M A, Chuang D M. Carbamazepine inhibition of N -methyl- d -aspartate-evoked calcium influx in rat cerebellar granule cells. J Pharmacol Exp Ther. 276:1996;143-149.